Literature DB >> 2495944

Emerging pathogens in nosocomial pneumonia.

S L Berk1, A Verghese.   

Abstract

The organisms responsible for nosocomial pneumonia are continuously evolving. Gram-negative bacilli have become the most common etiologic agents over the past 20 years, and with this evolution has come a better understanding of the pathogenesis of gram-negative bacillary pneumonia. Some gram-positive cocci, such as enterococci, group B beta hemolytic streptococci and methicillin-resistant Staphylococcus aureus, haven taken on new significance in nosocomial respiratory infections. Streptococcus pneumoniae, nontypeable Haemophilus influenzae and Branhamella catarrhalis are increasingly reported in hospitalized patients with chronic lung disease. Etiologic agents will change as new antibiotics are introduced. A better understanding of etiologic agents and their pathogens may be the best tool toward preventing hospital-acquired pneumonia.

Entities:  

Mesh:

Year:  1989        PMID: 2495944     DOI: 10.1007/bf01964113

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  A Study of a Type I Pneumococcus Epidemic at the State Hospital at Worcester, Mass.

Authors:  W G Smillie; G H Warnock; H J White
Journal:  Am J Public Health Nations Health       Date:  1938-03

2.  Isolation of beta-hemolytic streptococci from the respiratory tract: distribution and clinical significance.

Authors:  O Ekenna; A Verghese; A Karnad; P Basile; S L Berk
Journal:  Am J Med Sci       Date:  1988-02       Impact factor: 2.378

3.  Enterococcal pneumonia. Occurrence in patients receiving broad-spectrum antibiotic regimens and enteral feeding.

Authors:  S L Berk; A Verghese; S A Holtsclaw; J K Smith
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

4.  Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area.

Authors:  C S Bryan; K L Reynolds
Journal:  Am Rev Respir Dis       Date:  1984-05

5.  Bacteremic pneumonia due to gram-negative bacilli.

Authors:  J P Phair; H P Bassaris; J E Williams; E Metzger
Journal:  Arch Intern Med       Date:  1983-11

6.  Comparison of community-acquired and nosocomial pneumococcal bacteremia.

Authors:  J M Mylotte; T R Beam
Journal:  Am Rev Respir Dis       Date:  1981-03

7.  Group b Streptococcal pneumonia in the elderly.

Authors:  A Verghese; S L Berk; L J Boelen; J K Smith
Journal:  Arch Intern Med       Date:  1982-09

8.  A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis.

Authors:  T F Patterson; J E Patterson; B L Masecar; G E Barden; W J Hierholzer; M J Zervos
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

9.  Mixed Streptococcus pneumoniae and gram-negative bacillary pneumonia in the elderly.

Authors:  S L Berk; S L Wiener; L B Eisner; J W Duncan; J K Smith
Journal:  South Med J       Date:  1981-02       Impact factor: 0.954

10.  Nosocomial pneumococcal bacteremia.

Authors:  S Alvarez; J Guarderas; C G Shell; S Holtsclaw-Berk; S L Berk
Journal:  Arch Intern Med       Date:  1986-08
View more
  9 in total

Review 1.  Systemic antibiotic treatment of nosocomial pneumonia.

Authors:  K E Unertl; F P Lenhart; H Forst; K Peter
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 2.  Drug treatment of pneumonia in the hospital. What are the choices?

Authors:  M Aoun; J Klastersky
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 3.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation.

Authors:  Nicole R Luke; Amy J Howlett; Jianqiang Shao; Anthony A Campagnari
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  Prospective, randomized comparison of intravenous and oral ciprofloxacin with intravenous ceftazidime in the treatment of nosocomial pneumonia.

Authors:  R Saginur; G Garber; G Darling; S Shafran; W Cameron; G Jones; F Auclair
Journal:  Can J Infect Dis       Date:  1997-03

6.  Colonization and infection with Enterococcus faecalis in intensive care units: the role of antimicrobial agents.

Authors:  M J Bonten; C A Gaillard; F H van Tiel; S van der Geest; E E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

7.  Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia.

Authors:  J Rello; V Ausina; M Ricart; C Puzo; E Quintana; A Net; G Prats
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.

Authors:  Coleman Rotstein; Gerald Evans; Abraham Born; Ronald Grossman; R Bruce Light; Sheldon Magder; Barrie McTaggart; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

9.  Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities.

Authors:  Muhammad Arfat Yameen; Saira Iram; Abdul Mannan; Shujaat Ali Khan; Naeem Akhtar
Journal:  BMC Infect Dis       Date:  2013-03-27       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.